FDA Advisory No. 2020-1313 || Public Health Warning Against the Purchase and Use of the following Non-compliant Cosmetics:

The Food and Drug Administration (FDA) warns the public from purchasing and using the following non-compliant cosmetic products manufactured by Krystaricci Trading:

Product Names Notification Marketing Authorization Holder (MAH) Manufacturer 1. Neuwhite Gold Whitening Facial Serum NN-1000004961838 Wellnxt Corporation Address:Lg01 Cityland Shaw Tower, Shaw Blvd Cor St. Francis St, Barangay Wack Wack, Mandaluyong, Metro Manila             Krystaricci Trading Address: No. 14 Abao St., La Loma, Paang Bundok, Quezon City Metro Manila                 Krystaricci Trading Address: No. 14 Abao St., La Loma, Paang Bundok, Quezon City Metro Manila 2. Vartouhi Skinn 5-in-1 Intensive Skin Solution NN-1000005195029 Guanztech Enterprises Address: 151-F 18th Avenue Barangay East Rembo, Makati, Metro Manila   3. Vartouhi Vartouhi Skin Rejuvenate NN-1000005195016 4. Cercabella 24k Serum NN-1000005201786 5. Vartouhi Quiera Active Serum NN-1000005201744 6. Gels Beauty Product Concealer Stick NN-1000005218573 Gels Beauty Products Address: Kamagong St. Pamaldan Cabanatuan City Nueva Ecija 7. Gels Beauty Product Tawas Soap with Glutathione NN-1000005218586 8. Bubbly Skin Glow Serum NN-1000005160728 Bubbly Skin Address: Unit 7 – 1318 Agoncillo Townhomes 1, F. Agoncillo Street, Paco, Manila 9. Bubbly Skin Dream Whip Foam Wash NN-1000005180805 10. Fairy Cosmetics PH Fairy Air Tint NN-1000005224383 Fairy Jill Trading Address: Ugf-mbk New Point Mall, Santo Rosario, Angeles, Pampanga

The abovementioned products were post-evaluated by FDA as part of their postmarketing surveillance activities that Krystaricci Trading is not a holder of a License To Operate (LTO) as Manufacturer which render the subject products non-compliant pursuant to Book I, Article II, Section 2 of the Rules and Regulations Implementing Republic Act No. 9711, otherwise known as the “Food and Drug Administration Act of 2009” which provides for the relevant functions, powers and duties of the agency, including the conduct of PMS activities in the monitoring of health products.

Based on the Certificate of Product Notification issued to the company, any subsequent changes to the information previously submitted to the FDA will render the notification invalid, thus, a new notification will have to be submitted.

In light of the foregoing, the public is advised not to purchase the aforementioned violative cosmetic product. Moreover, the public is advised to always check if a cosmetic product is notified with the FDA through its website (www.fda.gov.ph). It has a Search feature which may be used by typing in the name of the product before deciding on purchasing and/or using the said product.

All concerned establishments are warned not to distribute violative cosmetic product until they have fully complied with the rules and regulation of the FDA.

All FDA Regional Field Offices and Regulatory Enforcement Units, in coordination with law enforcement agencies and Local Government Units, are requested to ensure that violative products are not sold or made available in the market or areas of their jurisdiction.

To report any sale, distribution, complaint and/or adverse event on the use of the violative cosmetic product, the online reporting facility, eReport can be accessed at [email protected], or call us at the Center for Cosmetics Regulation and Research (CCRR) hotline (02) 8857-1900 loc. 8113 or 8107.

Dissemination of this advisory to all concerned is hereby requested.

Attachment:->FDA Advisory No.2020-1313